Advanced search
Publication Cover
Cancer Biology & Therapy Volume 15, 2014 - Issue 8
Submit an article Journal homepage
1,362
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Rapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cells

Wei Chen Department of Hepatobiliary and Pancreatic Surgery; The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China
,
Qi-Da Hu Department of Hepatobiliary and Pancreatic Surgery; The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China
,
Xue-Feng Xia Department of Hepatobiliary and Pancreatic Surgery; The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China
,
Chao Liang Department of Hepatobiliary and Pancreatic Surgery; The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China
,
Hao Liu Department of Hepatobiliary and Pancreatic Surgery; The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China
,
Qi Zhang Department of Hepatobiliary and Pancreatic Surgery; The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China
,
Tao Ma Department of Hepatobiliary and Pancreatic Surgery; The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China
,
Feng Liang Department of Hepatobiliary and Pancreatic Surgery; The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China
&
Ting-Bo Liang Department of Hepatobiliary and Pancreatic Surgery; The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR ChinaCorrespondence[email protected]
 show all
Pages 992-999 | Received 08 Dec 2013, Accepted 05 May 2014, Published online: 06 May 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Fei Xue, Yanhui Liu, Hongwei Zhang, Yu Wen, Lei Yan, Qiang Tang, Erhui Xiao & Dongyi Zhang. (2016) Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression. OncoTargets and Therapy 9, pages 7253-7261.
Read now
A Grimaldi, D Santini, S Zappavigna, A Lombardi, G Misso, M Boccellino, V Desiderio, P P Vitiello, G Di Lorenzo, A Zoccoli, F Pantano & M Caraglia. (2015) Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells . Cancer Biology & Therapy 16:4, pages 567-579.
Read now

Articles from other publishers (8)

Jinglin Wang, Xiangyi Wu, Junqi Zhao, Haozhen Ren & Yuanjin Zhao. (2023) Developing Liver Microphysiological Systems for Biomedical Applications. Advanced Healthcare Materials.
Crossref
Zhentao Yang, Haiyang Xie, Jianqin Wan, Yuchen Wang, Liang Zhang, Ke Zhou, Hong Tang, Wentao Zhao, Hangxiang Wang, Penghong Song & Shusen Zheng. (2023) A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation. eBioMedicine 92, pages 104594.
Crossref
Weiwei Tang, Ziyi Chen, Wenling Zhang, Ye Cheng, Betty Zhang, Fan Wu, Qian Wang, Shouju Wang, Dawei Rong, F. P. Reiter, E. N. De Toni & Xuehao Wang. (2020) The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduction and Targeted Therapy 5:1.
Crossref
Ayse Erdogan & Aysun Ozkan. (2019) Cetuximab and epirubicin HCl-combined application as a possibility to treat both parental and epirubicin HCl-resistant liver cancer cells. Biologia Futura 70:3, pages 175-184.
Crossref
Aysun Ozkan, Ayse Erdogan, Odul Ozkan, Esra Manguoglu & Nadir Kiraz. (2019) Enhanced anticancer effect of cetuximab combined with stabilized silver ion solution in EGFR-positive lung cancer cells. Turkish Journal of Biochemistry 44:4, pages 426-437.
Crossref
Zhe Yang, Jian-Ji Li & Zan-Song Huang. (2019) Progress in basic and clinical research of targeted drugs for primary hepatocellular carcinoma. World Chinese Journal of Digestology 27:7, pages 450-458.
Crossref
Leilei Niu, Liping Liu, Shengli Yang, Jianwei Ren, Paul B.S. Lai & George G. Chen. (2017) New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:2, pages 564-570.
Crossref
Xu Sun, Qi Zhang, Wei Chen, Qida Hu, Yu Lou, Qi-Han Fu, Jing-Ying Zhang, Yi-Wen Chen, Long-Yun Ye, Yi Wang, Shang-Zhi Xie, Li-Qiang Hu, Ting-Bo Liang & Xue-Li Bai. (2017) Hook1 inhibits malignancy and epithelial–mesenchymal transition in hepatocellular carcinoma. Tumor Biology 39:7, pages 101042831771109.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.